← All Sponsors
SPONSOR

Ribocure Pharmaceuticals AB

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Dyslipidemias
NCT06797401 Phase 2
Recruiting

Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia

Dyslipidemias
Sweden View Trial →